ClinicalTrials.gov
ClinicalTrials.gov Menu

Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient Clinic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00436943
Recruitment Status : Terminated
First Posted : February 19, 2007
Last Update Posted : July 12, 2010
Sponsor:
Information provided by:
Atlantic Health System

Brief Summary:
The researchers hypothesize that smoking cessation counseling improves with the implementation of a smoking status assessment data sheet in routine consults. This is a quality improvement study design to evaluate the impact of the implementation of a more formal smoking status evaluation in a resident/faculty driven outpatient clinic.

Condition or disease Intervention/treatment
Smoking Drug: nicotine replacement therapy and bupropion Behavioral: smoking cessation counseling and referrals

Detailed Description:
We hypothesize that smoking cessation counseling improves with the implementation of a smoking status assessment data sheet in routine consults. This is a quality improvement study design to evaluate the impact of the implementation of a more formal smoking status evaluation in a resident/faculty driven outpatient clinic. This will be an observational study in which differences in quality measures will be compared between baseline and re-measurement periods. Population target: 900 patients screened before and after the implementation of the QI intervention. Primary outcome: smoking status evaluation. Secondary Outcome: number of patients advised to quit, plan implementation for smoking cessation, smoking cessation program referrals, number of NRT and bupropion prescription.

Study Type : Observational
Estimated Enrollment : 900 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Smoking Cessation Program: A Quality Improvement Trial in a Resident Based Outpatient Clinic
Study Start Date : January 2007
Estimated Study Completion Date : January 2008

Resource links provided by the National Library of Medicine

Drug Information available for: Bupropion
U.S. FDA Resources

Group/Cohort Intervention/treatment
A
Smokers
Drug: nicotine replacement therapy and bupropion
3-6 months
Behavioral: smoking cessation counseling and referrals
Organizational counseling and referrals




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Outpatient clinic
Criteria

Inclusion Criteria:

  • 21 years or older
  • Seen at MMH family health center
  • Current smoker

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00436943


Locations
United States, New Jersey
Family Health Center at Morristown Memorial Hospital
Morristown, New Jersey, United States, 07960
Sponsors and Collaborators
Atlantic Health System
Investigators
Principal Investigator: Patricia Harris, MD Atlantic Health System - Morristown Memorial Hospital

ClinicalTrials.gov Identifier: NCT00436943     History of Changes
Other Study ID Numbers: R06-12-021
Smoking Cessation
First Posted: February 19, 2007    Key Record Dates
Last Update Posted: July 12, 2010
Last Verified: July 2010

Keywords provided by Atlantic Health System:
smoking cessation
nicotine replacement therapy
bupropion
smoking

Additional relevant MeSH terms:
Nicotine
Bupropion
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Antidepressive Agents, Second-Generation
Antidepressive Agents
Psychotropic Drugs
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Dopamine Agents
Cytochrome P-450 CYP2D6 Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Enzyme Inhibitors